News | November 25, 2021
Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
The company is moving towards complex and more differentiated products
The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
It is the world’s first DNA-based Covid vaccine
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
Emkay Research expects Q2FY22 to be a normalised quarter for pharma companies that it tracks. A summary of the report
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Subscribe To Our Newsletter & Stay Updated
